US 8252933
2-oxo-1,2-dihydro-quinoline modulators of immune function
granted A61KA61K31/47A61K38/13
Quick answer
US patent 8252933 (2-oxo-1,2-dihydro-quinoline modulators of immune function) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/47, A61K38/13, A61K38/21, A61K39/3955